Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.85 $25,560 - $60,350
71,000 Added 1044.12%
77,800 $30,000
Q1 2024

May 15, 2024

BUY
$0.68 - $1.42 $952 - $1,988
1,400 Added 25.93%
6,800 $5,000
Q4 2023

Feb 14, 2024

SELL
$1.25 - $1.7 $61,625 - $83,810
-49,300 Reduced 90.13%
5,400 $7,000
Q3 2023

Nov 14, 2023

SELL
$1.54 - $2.15 $45,892 - $64,070
-29,800 Reduced 35.27%
54,700 $91,000
Q2 2023

Aug 14, 2023

SELL
$0.72 - $2.25 $3,528 - $11,025
-4,900 Reduced 5.48%
84,500 $178,000
Q1 2023

May 15, 2023

BUY
$0.9 - $1.45 $33,120 - $53,360
36,800 Added 69.96%
89,400 $94,000
Q4 2022

Feb 14, 2023

BUY
$1.14 - $2.99 $1,595 - $4,186
1,400 Added 2.73%
52,600 $60,000
Q3 2022

Nov 14, 2022

SELL
$0.62 - $5.76 $4,216 - $39,168
-6,800 Reduced 11.72%
51,200 $146,000

Others Institutions Holding MPLN

About MultiPlan Corp


  • Ticker MPLN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 639,073,984
  • Market Cap $121M
  • Description
  • MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and...
More about MPLN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.